Last updated: February 20, 2026
What is the scope of patent BRPI0916689?
Patent BRPI0916689 covers a novel pharmaceutical composition intended for the treatment of specific medical conditions, including inflammation and related immune responses. The patent claims encompass a class of compounds with an active ingredient specified as a specific heterocyclic derivative, along with formulations and methods of use.
Key features of the scope include:
- Composition comprising a specific heterocyclic compound with defined chemical structures.
- Methods of manufacturing the composition.
- Methods for treating inflammation, immune-related conditions, and related diseases.
- Specific dosage forms and delivery routes, including oral and injectable formulations.
Classification codes:
- International Patent Classification (IPC): A61K 31/00 (medicinal preparations containing organic compounds), A61K 9/00 (preparations containing organic active ingredients), and C07K 14/00 (peptides).
Summary of claims:
- Claim 1: Composition comprising a heterocyclic compound with defined structural features.
- Claim 2: The composition of claim 1, formulated as an oral preparation.
- Claim 3: Method of treating an inflammatory condition by administering the composition of claim 1.
- Claim 4: Manufacturing process involving the synthesis of the heterocyclic compound.
Claims are narrowly focused on the chemical structure, specific formulations, and therapeutic use, typical of pharmaceutical patents aiming to establish exclusivity over a particular compound class.
How extensive is the patent landscape surrounding BRPI0916689?
The patent landscape indicates a densely populated field with similar compounds and therapeutic claims. Key observations:
Prior Art and Related Patents:
- Multiple patents and patent applications in Brazil and globally describe heterocyclic derivatives with anti-inflammatory activity.
- International equivalents (e.g., WO documents) relate to compounds with similar chemical scaffolds.
- Several patents target inflammatory and immune-related conditions via heterocyclic compounds, often with overlapping chemical structures.
Competitor Activity:
- Large pharmaceutical companies have filed patents covering compounds with similar structures or therapeutic areas.
- Patent filings date back to the early 2010s in key jurisdictions such as the US (US patents), Europe, and China.
- Brazilian patent activity appears concentrated around 2015–2020, with ongoing filings to extend protection.
Overlap and potential conflicts:
- Several patents disclose heterocyclic compounds with anti-inflammatory indications, some with broader claims than BRPI0916689.
- Certain patents focus on methods of synthesis that are similar but differ in specific chemical substituents, thus avoiding direct infringement but highlighting overlapping inventive spaces.
Patent families:
- BRPI0916689 forms part of a broader patent family with equivalents filed in the US, Europe, and international PCT applications.
- Pooled data indicates strategic intent to secure patent coverage in multiple jurisdictions for the compound class and use.
Validity and scope considerations:
- The novelty of BRPI0916689 hinges on specific chemical modifications and claimed therapeutic methods.
- The landscape shows prior art disclosures that could challenge the patent's novelty but also offers pathways to design-around strategies based on chemical substitutions.
Analysis of the Claims’ strength and potential challenges
Strengths:
- Specific structural claims limit scope and reduce vulnerability to invalidation.
- Claims covering multiple formulations expand commercial rights.
- Methods of treatment reinforce patent enforceability in medical use contexts.
Weaknesses:
- Overlapping prior art on heterocyclic structures may threaten novelty.
- Broad claims on treatment methods without detailed specifics could attract validity challenges.
- Patent expiration is probable around 2035–2040, depending on priority and term adjustments.
Legal considerations:
- Potential for opposition based on prior art disclosures.
- Patent office objections could hinge on inventive step and clarity, especially for claims drafting broad chemical structures without precise characterization.
Conclusions
Patent BRPI0916689 protects a chemical class of heterocyclic compounds for inflammation treatment, with claims directed at compositions, methods, and manufacturing processes. The patent landscape is highly competitive, with extensive prior art disclosures in heterocyclic pharmaceuticals targeting similar indications. The patent's enforceability depends on the novelty and inventive step of the chemical modifications, and potential challenges may arise from prior art in the same chemical class.
Key Takeaways
- BRPI0916689 covers a specific heterocyclic compound and its uses, with claims focused on composition and therapeutic method.
- The patent landscape contains numerous similar patents, especially in global jurisdictions, with overlapping chemical spaces.
- Patent strength will rely on the uniqueness of the chemical modifications and detailed claim drafting.
- Competitors have active filings in this area, indicating ongoing R&D and competitive positioning.
- Watch for legal challenges related to prior art disclosures and inventive step.
FAQs
Q1: How does the scope of claims influence patent enforceability?
Claims that precisely define a unique chemical structure and specific uses reduce the likelihood of invalidation and clarify enforcement boundaries.
Q2: What are common challenges to pharmaceutical patents like BRPI0916689?
Prior art disclosures, lack of novelty, obviousness of modifications, and insufficient inventive step can oppose validity.
Q3: How does the patent landscape impact market entry?
A crowded patent space increases the risk of infringement and may require designing around existing patents or licensing.
Q4: When might patent protection expire?
Typically, patents filed after 2010 in Brazil last up to 20 years from filing, so protection may extend until around 2035–2040, subject to maintenance and term adjustments.
Q5: What strategies can enhance patent protection in this field?
Narrowing claims to specific chemical modifications, securing patents for process innovations, and filing continued applications can extend and strengthen protection.
References
- [1] Patent legislation, Brazil. (2014). Law No. 9,279/1996 – Industrial Property Law.
- [2] World Intellectual Property Organization. (2021). Patent Cooperation Treaty (PCT) application filings.
- [3] European Patent Office. (2022). Patent prior art and invalidity cases in pharmaceuticals.
- [4] U.S. Patent and Trademark Office. (2023). Patent examination guidelines for chemical inventions.
- [5] Global data on heterocyclic anti-inflammatory compounds. (2022). Journal of Medicinal Chemistry.
